chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, White blood cell count
Clinical narrative: had at least 3 nosebleeds in the last month out of nowhere; rash on the upper neck and around her chest and around her blossom; head aches; fever; muscle aches; chills; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (had at least 3 nosebleeds in the last month out of nowhere), RASH (rash on the upper neck and around her chest and around her blossom), HEADACHE (head aches), PYREXIA (fever) and MYALGIA (muscle aches) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EPISTAXIS (had at least 3 nosebleeds in the last month out of nowhere), RASH (rash on the upper neck and around her chest and around her blossom), HEADACHE (head aches), PYREXIA (fever), MYALGIA (muscle aches) and CHILLS (chills). The patient was treated with IBUPROFEN (ADVIL HEADACHE & MIGRAINE) for Pain head, at a dose of 1 dosage form. At the time of the report, EPISTAXIS (had at least 3 nosebleeds in the last month out of nowhere), RASH (rash on the upper neck and around her chest and around her blossom), HEADACHE (head aches), PYREXIA (fever), MYALGIA (muscle aches) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, White blood cell count: decreased (Low) white blood cells have taken a big decline.         No concomitant medications were reported.  Treatment medication included Steroid cream for the rash.   Reporter did not allow further contact
Age: 50.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vial first puncture for 4 patients was on 5/17/2021 and these 4 patients received vaccine on 5/18/2021 and 5/20/2021; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vial first puncture for 4 patients was on 5/17/2021 and these 4 patients received vaccine on 5/18/2021 and 5/20/2021) in a 50-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 027C21A) for COVID-19 vaccination.     No Medical History information was reported.   In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In May 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vial first puncture for 4 patients was on 5/17/2021 and these 4 patients received vaccine on 5/18/2021 and 5/20/2021). In May 2021, EXPIRED PRODUCT ADMINISTERED (Vial first puncture for 4 patients was on 5/17/2021 and these 4 patients received vaccine on 5/18/2021 and 5/20/2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not reported. It was reported that four patients were given vaccine dose number one outside the 12 hour first puncture expiration. Two patients received the vaccine on 18-May-2021 and two patients received the vaccine on 20-May-2021. The patient's races were reported. The patients had no adverse reaction. There was no treatment information reported.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Headache, Incorrect dose administered, Rash, White blood cell count
Clinical narrative: Head aches, head ache for more than 3 weeks; Had at least 3 nosebleeds in the last month out of nowhere; Rash on the upper neck and around her chest and around her blossom; Reporter is concerned that the vaccine was tampered with or given the wrong dose; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Head aches, head ache for more than 3 weeks), EPISTAXIS (Had at least 3 nosebleeds in the last month out of nowhere), RASH (Rash on the upper neck and around her chest and around her blossom) and INCORRECT DOSE ADMINISTERED (Reporter is concerned that the vaccine was tampered with or given the wrong dose) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In May 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Head aches, head ache for more than 3 weeks), EPISTAXIS (Had at least 3 nosebleeds in the last month out of nowhere), RASH (Rash on the upper neck and around her chest and around her blossom) and INCORRECT DOSE ADMINISTERED (Reporter is concerned that the vaccine was tampered with or given the wrong dose). The patient was treated with IBUPROFEN (ADVIL MIGRAINE) ongoing since an unknown date for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (Head aches, head ache for more than 3 weeks), EPISTAXIS (Had at least 3 nosebleeds in the last month out of nowhere) and RASH (Rash on the upper neck and around her chest and around her blossom) outcome was unknown and INCORRECT DOSE ADMINISTERED (Reporter is concerned that the vaccine was tampered with or given the wrong dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, White blood cell count: decreased (abnormal) white blood cells decreased.         No concomitant medications were provided. Steroid cream for the rash was taken by the patient to alleviate the symptoms experienced.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Gait inability, Mobility decreased, Muscle tightness, Pain
Clinical narrative: Couldn't walk; Muscle really tight; Excruciating pain; Couldn't lay down; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Jul-2021 and was forwarded to Moderna on 02-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (Couldn't walk), MUSCLE TIGHTNESS (Muscle really tight), PAIN (Excruciating pain) and MOBILITY DECREASED (Couldn't lay down) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     Concurrent medical conditions included Liver disorder (on dialysis 3 days per week with stage 5 liver disease).   On 02-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Jun-2021, the patient experienced GAIT INABILITY (Couldn't walk), MUSCLE TIGHTNESS (Muscle really tight), PAIN (Excruciating pain) and MOBILITY DECREASED (Couldn't lay down). At the time of the report, GAIT INABILITY (Couldn't walk), MUSCLE TIGHTNESS (Muscle really tight), PAIN (Excruciating pain) and MOBILITY DECREASED (Couldn't lay down) outcome was unknown.            No concomitant medications were reported.  Treatment medications included muscle relaxer, unspecified.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Vaccination site movement impairment, Vaccination site pain
Clinical narrative: Arm could not move to the back/ lasted for more than one month, but did not affect the hand function; Sore arm; Fever (102); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Arm could not move to the back/ lasted for more than one month, but did not affect the hand function), VACCINATION SITE PAIN (Sore arm) and PYREXIA (Fever (102)) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced PYREXIA (Fever (102)). On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Arm could not move to the back/ lasted for more than one month, but did not affect the hand function) and VACCINATION SITE PAIN (Sore arm). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Arm could not move to the back/ lasted for more than one month, but did not affect the hand function), VACCINATION SITE PAIN (Sore arm) and PYREXIA (Fever (102)) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Apr-2021, Body temperature: 102 (High) Had fever of 102.         No Concomitant product use was reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow-up was received and contains no new information. On 25-Aug-2021: Non significant follow-up received.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: terrible reaction to the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (terrible reaction to the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (terrible reaction to the vaccine). At the time of the report, VACCINATION COMPLICATION (terrible reaction to the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was mentioned. No treatment medication was mentioned.
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Interchange of vaccine products
Clinical narrative: patient had the 2nd dose but received a NON- Moderna COVID-19 vaccine instead of Moderna.; Patient received the second dose more than 42 days after the first dose; This spontaneous case was reported by a nurse and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (patient had the 2nd dose but received a NON- Moderna COVID-19 vaccine instead of Moderna.) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received the second dose more than 42 days after the first dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.   In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2. On 01-Jul-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (patient had the 2nd dose but received a NON- Moderna COVID-19 vaccine instead of Moderna.) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received the second dose more than 42 days after the first dose). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (patient had the 2nd dose but received a NON- Moderna COVID-19 vaccine instead of Moderna.) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received the second dose more than 42 days after the first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant Medications was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Abdominal pain upper
Clinical narrative: Upper Abdominal Pain/ cramping; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Upper Abdominal Pain/ cramping) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (Upper Abdominal Pain/ cramping). At the time of the report, ABDOMINAL PAIN UPPER (Upper Abdominal Pain/ cramping) outcome was unknown.            Concomitant medication was not provided.  Treatment information was not provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Headache, Inappropriate schedule of product administration, Loss of personal independence in daily activities
Clinical narrative: Seriously affected my work and life; Dizziness continued until now; Started to have a headache; knee cramps and pain; knee continued to ache; 04/20 First dose and Second dose on 05/28 Covid-19 Modena vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (04/20 First dose and Second dose on 05/28 Covid-19 Modena vaccine), DIZZINESS (Dizziness continued until now), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Seriously affected my work and life), ARTHRALGIA (knee cramps and pain; knee continued to ache) and HEADACHE (Started to have a headache) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (04/20 First dose and Second dose on 05/28 Covid-19 Modena vaccine). On 01-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ARTHRALGIA (knee cramps and pain; knee continued to ache). On 16-Jun-2021, the patient experienced DIZZINESS (Dizziness continued until now) and HEADACHE (Started to have a headache). On an unknown date, the patient experienced LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Seriously affected my work and life). The patient was treated with Manual therapy (Acupuncture) for Arthralgia. On 28-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (04/20 First dose and Second dose on 05/28 Covid-19 Modena vaccine) had resolved. On 14-Jun-2021, ARTHRALGIA (knee cramps and pain; knee continued to ache) had resolved. At the time of the report, DIZZINESS (Dizziness continued until now) had not resolved and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Seriously affected my work and life) and HEADACHE (Started to have a headache) outcome was unknown.            Concomitant product information was not provided. The patient received acupuncture on 08 June 2021. The pain was relieved, but two hours later the knee continued to ache.  Treatment information also included Chiropractic and massage, but nothing worked. On 12 July 2021, the patient had an appointment for an MRI.
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue
Clinical narrative: This spontaneous case was reported by a patient family member or friend and describes the occurrence of DECREASED APPETITE (appetite is cut in half at least) and FATIGUE (fatigued) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (appetite is cut in half at least) and FATIGUE (fatigued). At the time of the report, DECREASED APPETITE (appetite is cut in half at least) and FATIGUE (fatigued) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was reported. No treatment medication was reported.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Illness, Nasal congestion
Clinical narrative: Very sick /pretty sick; Tired; Congestion; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Very sick /pretty sick), FATIGUE (Tired) and NASAL CONGESTION (Congestion) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007C21A and 008B21-2A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Lung congestion (Chronic lung congestion for 7 years) and Cough (pretty much every day.). Concomitant products included PREDNISONE for Inflammation localised.   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (Very sick /pretty sick), FATIGUE (Tired) and NASAL CONGESTION (Congestion). At the time of the report, ILLNESS (Very sick /pretty sick), FATIGUE (Tired) and NASAL CONGESTION (Congestion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Other concomitant medications were  Blood pressure medications 3 and blood thinner, unspecified.  Treatment medications were  typical decongestant medicine, unspecified.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: C-reactive protein, Fatigue, Red blood cell sedimentation rate
Clinical narrative: fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Cranial nerve disorder since 23-Jun-2021 and Temporal arteritis since 23-Jun-2021.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced FATIGUE (fatigue). On 04-Feb-2021, FATIGUE (fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jun-2021, Red blood cell sedimentation rate (0-30): normal (normal) 0-30 normal she was at 51.2. On an unknown date, C-reactive protein (0-6): normal (normal) 0-6 is normal she was at 52.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. Patient received first vaccine on 03 FEB 2021. Patient felt fatigue right after her and stated the fatigue went away 1 day later. No treatment information was provided.   This case was linked to MOD-2021-245698 (Patient Link).
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: C-reactive protein, Cranial nerve disorder, Diplopia, Eye pain, Fatigue
Clinical narrative: Cranial nerve; Temporal arteritis; Episode of double vision and eye pain; Episode of double vision and eye pain; Deep scalp tenderness; Pain; Jaw and tongue tiredness; Tenderness around ear/tenderness around eyes; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN OF SKIN (Deep scalp tenderness), PAIN (Pain), DIPLOPIA (Episode of double vision and eye pain), EYE PAIN (Episode of double vision and eye pain) and CRANIAL NERVE DISORDER (Cranial nerve) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 10-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (Fatigue). On 30-Apr-2021, the patient experienced PAIN OF SKIN (Deep scalp tenderness), PAIN (Pain), FATIGUE (Jaw and tongue tiredness) and TENDERNESS (Tenderness around ear/tenderness around eyes). On 21-Jun-2021, the patient experienced DIPLOPIA (Episode of double vision and eye pain) and EYE PAIN (Episode of double vision and eye pain). On 23-Jun-2021, the patient experienced CRANIAL NERVE DISORDER (Cranial nerve) and GIANT CELL ARTERITIS (Temporal arteritis). The patient was treated with PREDNISONE for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN OF SKIN (Deep scalp tenderness), PAIN (Pain), DIPLOPIA (Episode of double vision and eye pain), EYE PAIN (Episode of double vision and eye pain), CRANIAL NERVE DISORDER (Cranial nerve), GIANT CELL ARTERITIS (Temporal arteritis), FATIGUE (Fatigue), FATIGUE (Jaw and tongue tiredness) and TENDERNESS (Tenderness around ear/tenderness around eyes) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jun-2021, C-reactive protein (0-6): 52 High. On 23-Jun-2021, Red blood cell sedimentation rate increased (0-30): 51.2 High. On 23-Jun-2021, Weight: decreased (abnormal) weight decreased..         No concomitant medications were mentioned.   This case was linked to MOD-2021-245694 (Patient Link).
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Giant cell arteritis, Pain, Pain of skin, Red blood cell sedimentation rate increased, Tenderness
Clinical narrative: Cranial nerve; Temporal arteritis; Episode of double vision and eye pain; Episode of double vision and eye pain; Deep scalp tenderness; Pain; Jaw and tongue tiredness; Tenderness around ear/tenderness around eyes; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN OF SKIN (Deep scalp tenderness), PAIN (Pain), DIPLOPIA (Episode of double vision and eye pain), EYE PAIN (Episode of double vision and eye pain) and CRANIAL NERVE DISORDER (Cranial nerve) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 10-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (Fatigue). On 30-Apr-2021, the patient experienced PAIN OF SKIN (Deep scalp tenderness), PAIN (Pain), FATIGUE (Jaw and tongue tiredness) and TENDERNESS (Tenderness around ear/tenderness around eyes). On 21-Jun-2021, the patient experienced DIPLOPIA (Episode of double vision and eye pain) and EYE PAIN (Episode of double vision and eye pain). On 23-Jun-2021, the patient experienced CRANIAL NERVE DISORDER (Cranial nerve) and GIANT CELL ARTERITIS (Temporal arteritis). The patient was treated with PREDNISONE for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN OF SKIN (Deep scalp tenderness), PAIN (Pain), DIPLOPIA (Episode of double vision and eye pain), EYE PAIN (Episode of double vision and eye pain), CRANIAL NERVE DISORDER (Cranial nerve), GIANT CELL ARTERITIS (Temporal arteritis), FATIGUE (Fatigue), FATIGUE (Jaw and tongue tiredness) and TENDERNESS (Tenderness around ear/tenderness around eyes) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jun-2021, C-reactive protein (0-6): 52 High. On 23-Jun-2021, Red blood cell sedimentation rate increased (0-30): 51.2 High. On 23-Jun-2021, Weight: decreased (abnormal) weight decreased..         No concomitant medications were mentioned.   This case was linked to MOD-2021-245694 (Patient Link).
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Weight
Clinical narrative: Cranial nerve; Temporal arteritis; Episode of double vision and eye pain; Episode of double vision and eye pain; Deep scalp tenderness; Pain; Jaw and tongue tiredness; Tenderness around ear/tenderness around eyes; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN OF SKIN (Deep scalp tenderness), PAIN (Pain), DIPLOPIA (Episode of double vision and eye pain), EYE PAIN (Episode of double vision and eye pain) and CRANIAL NERVE DISORDER (Cranial nerve) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 10-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (Fatigue). On 30-Apr-2021, the patient experienced PAIN OF SKIN (Deep scalp tenderness), PAIN (Pain), FATIGUE (Jaw and tongue tiredness) and TENDERNESS (Tenderness around ear/tenderness around eyes). On 21-Jun-2021, the patient experienced DIPLOPIA (Episode of double vision and eye pain) and EYE PAIN (Episode of double vision and eye pain). On 23-Jun-2021, the patient experienced CRANIAL NERVE DISORDER (Cranial nerve) and GIANT CELL ARTERITIS (Temporal arteritis). The patient was treated with PREDNISONE for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN OF SKIN (Deep scalp tenderness), PAIN (Pain), DIPLOPIA (Episode of double vision and eye pain), EYE PAIN (Episode of double vision and eye pain), CRANIAL NERVE DISORDER (Cranial nerve), GIANT CELL ARTERITIS (Temporal arteritis), FATIGUE (Fatigue), FATIGUE (Jaw and tongue tiredness) and TENDERNESS (Tenderness around ear/tenderness around eyes) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jun-2021, C-reactive protein (0-6): 52 High. On 23-Jun-2021, Red blood cell sedimentation rate increased (0-30): 51.2 High. On 23-Jun-2021, Weight: decreased (abnormal) weight decreased..         No concomitant medications were mentioned.   This case was linked to MOD-2021-245694 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: First dose given 01/11/2021, employee now requesting 2nd dose.; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose given 01/11/2021, employee now requesting 2nd dose.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jul-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose given 01/11/2021, employee now requesting 2nd dose.). On 02-Jul-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose given 01/11/2021, employee now requesting 2nd dose.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant medications were not provided.  Treatment medication was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (After his 1st dose, he was fine, he had some normal pain for a few days, after that, the aching went away, and he was fine.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (After his 1st dose, he was fine, he had some normal pain for a few days, after that, the aching went away, and he was fine). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, MYALGIA (After his 1st dose, he was fine, he had some normal pain for a few days, after that, the aching went away, and he was fine) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications was reported. This case was linked to MOD-2021-245562 (Patient Link).
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Gave a patient a first dose on 1Jul2021 Patient was 14 years old come in and take a dose of vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Gave a patient a first dose on 1Jul2021 Patient was 14 years old come in and take a dose of vaccine) in a 14-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Gave a patient a first dose on 1Jul2021 Patient was 14 years old come in and take a dose of vaccine). On 01-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Gave a patient a first dose on 1Jul2021 Patient was 14 years old come in and take a dose of vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant medications were not provided.  Treatment medication was not provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Vaccination site erythema
Clinical narrative: Sore arm for a day or two; Hand swelled a little bit; Right arm got red too in some parts; Left arm developed a big red area that went from the vaccination area down to the rest; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm for a day or two), PERIPHERAL SWELLING (Hand swelled a little bit), ERYTHEMA (Right arm got red too in some parts) and VACCINATION SITE ERYTHEMA (Left arm developed a big red area that went from the vaccination area down to the rest) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SIMVASTATIN for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm for a day or two), PERIPHERAL SWELLING (Hand swelled a little bit) and ERYTHEMA (Right arm got red too in some parts). an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Left arm developed a big red area that went from the vaccination area down to the rest). At the time of the report, PAIN IN EXTREMITY (Sore arm for a day or two) had resolved and PERIPHERAL SWELLING (Hand swelled a little bit), ERYTHEMA (Right arm got red too in some parts) and VACCINATION SITE ERYTHEMA (Left arm developed a big red area that went from the vaccination area down to the rest) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Additional concomitant medications included unknown water pill.  Treatment information was not provided.   This case was linked to MOD-2021-245639 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RASH (The caller spoke about a neighbor friend that had a bad rash but was fine a few days later) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (The caller spoke about a neighbor friend that had a bad rash but was fine a few days later). At the time of the report, RASH (The caller spoke about a neighbor friend that had a bad rash but was fine a few days later) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. No treatment medications were reported.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient received 1st dose of the vaccine on 14APR2021 and has not received the 2nd dose yet; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient received 1st dose of the vaccine on 14APR2021 and has not received the 2nd dose yet) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient received 1st dose of the vaccine on 14APR2021 and has not received the 2nd dose yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient received 1st dose of the vaccine on 14APR2021 and has not received the 2nd dose yet) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information were not provided
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Antibody test, Asthenia, Dizziness, Dyspepsia
Clinical narrative: This spontaneous case was reported by a health care professional and describes the occurrence of ILLNESS (severely ill), ABDOMINAL DISCOMFORT (Upset stomach), DYSPNOEA (Shortness of breath), ASTHENIA (Weakness) and GAIT DISTURBANCE (Could not even walk) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (severely ill), ABDOMINAL DISCOMFORT (Upset stomach), DYSPNOEA (Shortness of breath), ASTHENIA (Weakness), GAIT DISTURBANCE (Could not even walk), DYSPEPSIA (Digestive problems), DIZZINESS (Dizziness), PYREXIA (Fever), NAUSEA (Nausea), FATIGUE (Fatigue) and HEADACHE (Headaches). At the time of the report, ILLNESS (severely ill), ABDOMINAL DISCOMFORT (Upset stomach), DYSPNOEA (Shortness of breath), ASTHENIA (Weakness), GAIT DISTURBANCE (Could not even walk), DYSPEPSIA (Digestive problems), DIZZINESS (Dizziness), PYREXIA (Fever), NAUSEA (Nausea), FATIGUE (Fatigue) and HEADACHE (Headaches) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: high count of antibodies (High) high count of antibodies. On an unknown date, Heart rate: increased (High) Rapid heart rate. On an unknown date, Weight: decreased (Inconclusive) loss of weight. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not provided by reporter. Treatment information was not provided by reporter.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Gait disturbance, Headache, Heart rate
Clinical narrative: This spontaneous case was reported by a health care professional and describes the occurrence of ILLNESS (severely ill), ABDOMINAL DISCOMFORT (Upset stomach), DYSPNOEA (Shortness of breath), ASTHENIA (Weakness) and GAIT DISTURBANCE (Could not even walk) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (severely ill), ABDOMINAL DISCOMFORT (Upset stomach), DYSPNOEA (Shortness of breath), ASTHENIA (Weakness), GAIT DISTURBANCE (Could not even walk), DYSPEPSIA (Digestive problems), DIZZINESS (Dizziness), PYREXIA (Fever), NAUSEA (Nausea), FATIGUE (Fatigue) and HEADACHE (Headaches). At the time of the report, ILLNESS (severely ill), ABDOMINAL DISCOMFORT (Upset stomach), DYSPNOEA (Shortness of breath), ASTHENIA (Weakness), GAIT DISTURBANCE (Could not even walk), DYSPEPSIA (Digestive problems), DIZZINESS (Dizziness), PYREXIA (Fever), NAUSEA (Nausea), FATIGUE (Fatigue) and HEADACHE (Headaches) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: high count of antibodies (High) high count of antibodies. On an unknown date, Heart rate: increased (High) Rapid heart rate. On an unknown date, Weight: decreased (Inconclusive) loss of weight. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not provided by reporter. Treatment information was not provided by reporter.
Sex: F
Vaccine: COVID19
Symptoms: Illness, Nausea, Pyrexia, Weight
Clinical narrative: This spontaneous case was reported by a health care professional and describes the occurrence of ILLNESS (severely ill), ABDOMINAL DISCOMFORT (Upset stomach), DYSPNOEA (Shortness of breath), ASTHENIA (Weakness) and GAIT DISTURBANCE (Could not even walk) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (severely ill), ABDOMINAL DISCOMFORT (Upset stomach), DYSPNOEA (Shortness of breath), ASTHENIA (Weakness), GAIT DISTURBANCE (Could not even walk), DYSPEPSIA (Digestive problems), DIZZINESS (Dizziness), PYREXIA (Fever), NAUSEA (Nausea), FATIGUE (Fatigue) and HEADACHE (Headaches). At the time of the report, ILLNESS (severely ill), ABDOMINAL DISCOMFORT (Upset stomach), DYSPNOEA (Shortness of breath), ASTHENIA (Weakness), GAIT DISTURBANCE (Could not even walk), DYSPEPSIA (Digestive problems), DIZZINESS (Dizziness), PYREXIA (Fever), NAUSEA (Nausea), FATIGUE (Fatigue) and HEADACHE (Headaches) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: high count of antibodies (High) high count of antibodies. On an unknown date, Heart rate: increased (High) Rapid heart rate. On an unknown date, Weight: decreased (Inconclusive) loss of weight. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not provided by reporter. Treatment information was not provided by reporter.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (dry mouth) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The patient's past medical history included Carcinoma vocal cord (Vocal cords cancer). Concomitant products included VITAMINS NOS for an unknown indication. On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DRY MOUTH (dry mouth). At the time of the report, DRY MOUTH (dry mouth) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information reported. This case was linked to MOD-2021-246777 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032C20 and 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypersensitivity, Hives and Allergy to antibiotic (Causes Urticaria-swollen tongue). Concomitant products included RALOXIFENE HYDROCHLORIDE (EVISTA), ATORVASTATIN CALCIUM (LIPITOR), NADOLOL (CORGARD), BIFIDOBACTERIUM INFANTIS (ALIGN), CYANOCOBALAMIN (VITAMIN B-12), VITAMIN D3 and UBIDECARENONE (COQ10 [UBIDECARENONE]) for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.2 - 99.5 (High) 99.2-99.5 high during the day..         TB test was done on 30JAN2021, result was unknown and on unknown date COVID-19  fast test and the longer one was done both were negative is the lab data reported by reporter. No treatment medications provided by the reporter.   Patient stated that 3 days before her second vaccination she lasted her taste.   This case was linked to MOD-2021-019760 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Flare ups due to vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Flare ups due to vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Flare ups due to vaccine). At the time of the report, VACCINATION COMPLICATION (Flare ups due to vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.  No treatment information was provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION COMPLICATION (Severe Reaction from the Moderna COVID-19 injection) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 25-May-2021, the patient experienced VACCINATION COMPLICATION (Severe Reaction from the Moderna COVID-19 injection). At the time of the report, VACCINATION COMPLICATION (Severe Reaction from the Moderna COVID-19 injection) had not resolved. Patient was taken to the hospital by ambulance. No other details provided. Follow-up required. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. According to a social media post, on 25-May-2021, the patient suffered a severe reaction after receiving the Moderna Vaccine and on 22-Jun-2021, the patient was again transported to the hospital by ambulance. No additional reports have been received at this time. Reporter did not allow further contact.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Breast pain, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ASTHMA (Asthma attack on Saturday night), PYREXIA (Low grade fever) and BREAST PAIN (Breast pain on same side as the shot) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 032B21A) for COVID-19 vaccination. Concomitant products included METFORMIN from 26-Jun-2021 to an unknown date and BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) from 26-Jun-2021 to an unknown date for an unknown indication. On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Jun-2021, the patient experienced ASTHMA (Asthma attack on Saturday night). On 02-Jul-2021, the patient experienced PYREXIA (Low grade fever) and BREAST PAIN (Breast pain on same side as the shot). At the time of the report, ASTHMA (Asthma attack on Saturday night), PYREXIA (Low grade fever) and BREAST PAIN (Breast pain on same side as the shot) outcome was unknown. Not Provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment medications were not provided by the reporter. Action taken with mRNA-1273 in response to the events were not Applicable. This case was linked to MOD-2021-245563 (Patient Link).